Aortic Stenosis with Normal Flow Low Gradient: Should We Intervene or Wait?

Symptomatic patients with <1 cm² aortic valve area will benefit from an intervention regardless parameters such as flow and gradient, even if these are normal (or at least not severe).

Masa miocárdica fraccional para evaluar la severidad de la estenosisA valve replacement will be indicated without question (either surgical or percutaneous) in patients with >40 mHg mean gradient or low gradient justified by low flow. Much has been said and written about these cases and much will still be written. However, little has been published about patients with normal flow and low gradient.

 

Should we trust aortic valve area blindly when indicating an intervention such as a valve replacement?


Read also: Ten Commandments of the European Hypertension Guidelines: Several “Sins Allowed” Compared with American Guidelines.


Many specialists might question the severity of stenosis in these patients, especially when symptoms can be explained by other causes such as pulmonary or coronary causes.

 

This study included symptomatic patients with ≤ 1 cm² valve area, <40 mmHg mean gradient and > 35 ml/m² stroke volume index.

 

During the study period,1358 patients were assessed, and 303 (34%) met inclusion criteria.


Read also: TAVR Post-dilation Is Safe.


After a mean follow up of nearly 2 years, 60 patients (20%) died, with a global rate of 28%, 10% and 12% in the conservative treatment branch, TAVR and surgery respectively (p<0.001).

 

After adjusting for multiple variables, TAVR was associated with survival improvement vs. the conservative treatment (HR: 0.49; CI 95%:0.26 to 0.93; p=0.03), with no significant differences between surgery and TAVR. What made the difference was the intervention, regardless the type.

 

Conclusion

Symptomatic patients with <1 cm² valve area will benefit from intervention in terms of survival regardless low gradient and normal flow. The type of intervention had no impact on outcomes.

 

Original title: Intervention Versus Observation in Symptomatic Patients with Normal Flow-Low Gradient Severe Aortic Stenosis.

Reference: Oren Zusman et al. J Am Coll Cardiol Img 2018. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....